167 related articles for article (PubMed ID: 30302057)
1. Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?
Zhang X; Fu X; Dong M; Yang Z; Wu S; Ma M; Li Z; Wang X; Li L; Li X; Sun Z; Chang Y; Nan F; Yan J; Mao Y; Zhang M; Chen Q
Cancer Cell Int; 2018; 18():150. PubMed ID: 30302057
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.
Gao M; Liu L; Zhang X; Li Z; Zhang M
Environ Toxicol Pharmacol; 2021 Jul; 85():103639. PubMed ID: 33771682
[TBL] [Abstract][Full Text] [Related]
3. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
[TBL] [Abstract][Full Text] [Related]
5. IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4.
Ni M; Qin B; Xie L; Zhang X; Yang J; Lv H; Yang M; Zhang M
Biomed Res Int; 2018; 2018():2606834. PubMed ID: 30643796
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
7. Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma.
Han L; Liu F; Li R; Li Z; Chen X; Zhou Z; Zhang X; Hu T; Zhang Y; Young K; Sun S; Wen J; Zhang M
Oncol Lett; 2014 Oct; 8(4):1461-1469. PubMed ID: 25202350
[TBL] [Abstract][Full Text] [Related]
8. DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
Wang X; Hu J; Dong M; Ding M; Zhu L; Wu J; Sun Z; Li X; Zhang L; Li L; Wang X; Fu X; Wang G; Chen Q; Zhang M; Zhang X
Clin Transl Sci; 2021 Jan; 14(1):405-411. PubMed ID: 33045134
[TBL] [Abstract][Full Text] [Related]
9. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
[TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report.
Li LJ; Zhang JY
World J Clin Cases; 2022 Oct; 10(28):10193-10200. PubMed ID: 36246799
[TBL] [Abstract][Full Text] [Related]
11. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
12. NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R
Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance.
Liu L; Zuo LF; Guo JW
Mol Med Rep; 2014 Apr; 9(4):1299-304. PubMed ID: 24535197
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
15. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
[TBL] [Abstract][Full Text] [Related]
16. Current treatment approaches for NK/T-cell lymphoma.
Yamaguchi M; Miyazaki K
J Clin Exp Hematop; 2017 Dec; 57(3):98-108. PubMed ID: 28679966
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
18. [Effect of doxorubicin on TRAIL resistance and TRAIL receptor expression in lymphoma cell line SNK-6 cells].
Zhang YC; Yang QP; Tang Y; Wang WY; Yu JB; Liu WP
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):651-4. PubMed ID: 24332050
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
Makita S; Tobinai K
Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
